MANILA – The Food and Drug Administration (FDA) confirmed receiving 25 reports related to the voluntary recall of certain batches of Nan Optipro and Nankid Optipro infant formula products. Eighteen of the reports involve health concerns observed in infants and young children after consuming the affected products, FDA said in a statement on Friday. Symptoms included vomiting, diarrhea, abdominal pain and other conditions, some requiring medical attention. READ: FDA probing Nestlé’s recall of baby formulas All reports related to the infant formula recall are being evaluated to determine the appropriate regulatory actions and are coordinated with concerned agencies and offices to ensure […]... Keep on reading: Infant formula recall: FDA reviews 25 cases linked to recall